IL-10 synthesis and secretion by peripheral blood mononuclear cells in haemodialysis patients

被引:22
作者
Brunet, P
Capo, C
Dellacasagrande, J
Thirion, X
Mege, JL
Berland, Y
机构
[1] Hop St Marguerite, Serv Nephrol, F-13009 Marseille, France
[2] Fac Med Marseille, CNRS UPRESA 6020, Unite Rickettsies, F-13385 Marseille, France
[3] Hop St Marguerite, Serv Informat Med, Marseille, France
关键词
haemodialysis; immunodeficiency; immunomodulation; interleukin-10; interleukin-6; peripheral blood mononuclear cells;
D O I
10.1093/ndt/13.7.1745
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of study. IL-10 may explain the paradox between immunodeficiency and oversecretion of cytokines in chronic haemodialysis (HD) patients. We analysed the secretion of IL-10 by PBMC and the expression of IL-10 mRNA in 10 long-term HD patients (108-276 months), 10 short-term HD patients (3-18 months), and 10 healthy controls. Results. Spontaneous IL-10 secretion was higher in HD patients than in controls (15 pg/ml vs 2 pg/ml, P=0.004). It was detected in 13 of 20 patients and in 1 of 10 controls (P=0.01). IL-10 mRNA expression was also higher in HD patients than in controls. Spontaneous secretions of IL-10 and IL-6 were positively correlated in patients. IL-10 secretion in response to LPS was higher than the upper limit of control range in 4 of 10 long-term HD patients and in no short-term HD patients (P=0.04). IL-10 mRNA expression was also higher in long-term than in shortterm HD patients. Conclusions. This study demonstrates that IL-10 is spontaneously synthesized and secreted in HD patients, supporting an immunomodulating role in this setting. The greater IL-10-producing capacity in long-term HD patients indicates a chronic effect of haemodialysis on PBMC responsiveness.
引用
收藏
页码:1745 / 1751
页数:7
相关论文
共 28 条
  • [1] Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis
    Capo, C
    Zugun, F
    Stein, A
    Tardei, G
    Lepidi, H
    Raoult, D
    Mege, JL
    [J]. INFECTION AND IMMUNITY, 1996, 64 (05) : 1638 - 1642
  • [2] Production of interleukin-10 and transforming growth factor beta by peripheral blood mononuclear cells in Q fever endocarditis
    Capo, C
    Zaffran, Y
    Zugun, F
    Houpikian, P
    Raoult, D
    Mege, JL
    [J]. INFECTION AND IMMUNITY, 1996, 64 (10) : 4143 - 4147
  • [3] CHATENOUD L, 1994, KIDNEY INT, V45, pS92
  • [4] DESCAMPSLATSCHA B, 1993, KIDNEY INT, V43, pS135
  • [5] UREMIC SERUM EFFECTS ON PERIPHERAL-BLOOD MONONUCLEAR CELL AND PURIFIED LYMPHOCYTE-T RESPONSES
    DONATI, D
    DEGIANNIS, D
    RASKOVA, J
    RASKA, K
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (03) : 681 - 689
  • [6] INDUCTION OF HAPTEN-SPECIFIC TOLERANCE BY INTERLEUKIN-10 IN-VIVO
    ENK, AH
    SALOGA, J
    BECKER, D
    MOHAMADZADEH, M
    KNOP, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1397 - 1402
  • [7] FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
  • [8] INFLUENCE OF AN ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODY ON CYTOKINE LEVELS IN PATIENTS WITH SEPSIS
    FISHER, CJ
    OPAL, SM
    DHAINAUT, JF
    STEPHENS, S
    ZIMMERMAN, JL
    NIGHTINGALE, P
    HARRIS, SJ
    SCHEIN, RMH
    PANACEK, EA
    VINCENT, JL
    FOULKE, GE
    WARREN, EL
    GARRARD, C
    PARK, G
    BODMER, MW
    COHEN, J
    VANDERLINDEN, C
    CROSS, AS
    SADOFF, JC
    GORECKI, J
    DUBIN, HG
    GARNER, C
    KAYE, W
    LANORE, JJ
    MIRA, JP
    ZIMMERMAN, J
    DELLINGER, RP
    TAYLOR, RW
    DAHL, S
    SHELLY, M
    MORTIMER, A
    EDWARDS, JD
    KETT, DH
    QUARTIN, A
    PENA, MA
    BAKKER, J
    ALBERSON, TE
    WALBY, W
    RADCLIFFE, J
    YOUNG, D
    MCQUILLAM, P
    BELLINGHAM, G
    BURMAN, W
    SADOFF, JS
    YOUNG, L
    [J]. CRITICAL CARE MEDICINE, 1993, 21 (03) : 318 - 327
  • [9] PRODUCTION OF INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-10 IN-VITRO CORRELATES WITH THE CLINICAL IMMUNE DEFECT IN CHRONIC-HEMODIALYSIS PATIENTS
    GIRNDT, M
    KOHLER, H
    SCHIEDHELMWEICK, E
    SCHLAAK, JF
    ZUMBUSCHENFELDE, KHM
    FLEISCHER, B
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (02) : 559 - 565
  • [10] GORCZYNSKI RM, 1994, J IMMUNOL, V152, P2011